Skip to main content
Bodal Chemicals Ltd logo

Bodal Chemicals Ltd — Investor Relations & Filings

Ticker · BODALCHEM ISIN · INE338D01028 LEI · 33580055P81L7PGHUJ40 BSE.NS Manufacturing
Open in API
Filings indexed 1,550 across all filing types
Latest filing 2023-04-04 Regulatory Filings
Country IN India
Listing BSE.NS BODALCHEM

About Bodal Chemicals Ltd

https://www.bodal.com/

Bodal Chemicals Ltd is a vertically integrated manufacturer specializing in dyestuffs, dye intermediates, and basic chemicals. The product portfolio includes a wide range of reactive, acid, and direct dyes, alongside key intermediates such as H-Acid and Vinyl Sulphone. The chemical division produces sulfuric acid, chloro sulfonic acid, and liquid sulfur trioxide. By maintaining a high degree of backward integration, the company ensures cost-efficiency and consistent quality across its manufacturing chain. It serves diverse global markets, primarily catering to the textile, leather, paper, and plastic sectors. The organization focuses on large-scale production capabilities and technical expertise to provide chemical solutions for industrial applications worldwide.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the receipt of an adjudication order under SEBI regulations. It discloses a penalty imposed on a connected party and clarifies that no direct case has been initiated against the company itself. The document is an intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015, which typically covers material event disclosures. The content is a regulatory announcement informing the exchanges and public about a legal/regulatory matter affecting the company. It does not contain financial statements, management discussion, or detailed report data. The document length is short (2051 characters) and serves as a notification rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-04-04 English
Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for period ended 31st March 2023.
Regulatory Filings
2023-04-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the closure of the trading window in compliance with insider trading regulations. It specifies the dates for the trading window closure around the financial results announcement but does not contain any financial data, results, or detailed report content. The document is short (1449 characters) and serves as an announcement related to regulatory compliance rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and procedural announcements.
2023-03-31 English
Bodal Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Regulatory Filings
2023-03-31 English
Bodal Chemicals Limited has informed the Exchange about Schedule of Analyst meet
Regulatory Filings
2023-03-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the schedule of analyst and institutional investor meetings. It explicitly states that the discussions will be based on publicly available information and no unpublished price sensitive information will be shared. The document is submitted pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(6), which pertains to disclosure of events or information. The content is an announcement of upcoming investor interactions rather than a detailed financial report, earnings release, or presentation. It does not contain financial data or detailed analysis but serves as a regulatory disclosure about investor meetings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-03-27 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.